Exact Mass: 1049.5505
Exact Mass Matches: 1049.5505
Found 12 metabolites which its exact mass value is equals to given mass value 1049.5505,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(Lycoperoside H) FA or (Hydroxy-α-Tomatine) FA III
(Lycoperoside H) FA or (Hydroxy-α-Tomatine) FA III
Solasodine base + 2H, 1O, O-Hex-Hex-Hex-Pen
Solasodine base + 2H, 1O, O-Hex-Hex-Hex-Pen
Annotation level-3
(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[(2-acetamidoacetyl)amino]propanoyl]amino]-5-amino-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-6-aminohexanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]propanoyl]amino]-6-aminohexanoic acid
(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[(2-acetamidoacetyl)amino]propanoyl]amino]-5-amino-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-6-aminohexanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]propanoyl]amino]-6-aminohexanoic acid
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C129821 - Antineoplastic Biological Agent C307 - Biological Agent
2-[(2-{[4,5-dihydroxy-6-({22-hydroxy-10,14,16,20-tetramethyl-23-oxa-18-azahexacyclo[12.11.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁴.0¹⁷,²²]pentacosan-7-yl}oxy)-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
2-[(2-{[4,5-dihydroxy-6-({22-hydroxy-10,14,16,20-tetramethyl-23-oxa-18-azahexacyclo[12.11.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁴.0¹⁷,²²]pentacosan-7-yl}oxy)-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2z)-n-[(3s,6s,9e,12s,23s,26r,27s,30s,32r)-20-benzyl-6-[(2s)-butan-2-yl]-9-ethylidene-5,8,11,22,25,32-hexahydroxy-3-[2-(c-hydroxycarbonimidoyl)ethyl]-23-(methoxymethyl)-18,27-dimethyl-2,17,19,29-tetraoxo-28-oxa-1,4,7,10,16,21,24-heptaazatricyclo[28.3.0.0¹²,¹⁶]tritriaconta-4,7,10,21,24-pentaen-26-yl]-2-methylhex-2-enimidic acid
(2z)-n-[(3s,6s,9e,12s,23s,26r,27s,30s,32r)-20-benzyl-6-[(2s)-butan-2-yl]-9-ethylidene-5,8,11,22,25,32-hexahydroxy-3-[2-(c-hydroxycarbonimidoyl)ethyl]-23-(methoxymethyl)-18,27-dimethyl-2,17,19,29-tetraoxo-28-oxa-1,4,7,10,16,21,24-heptaazatricyclo[28.3.0.0¹²,¹⁶]tritriaconta-4,7,10,21,24-pentaen-26-yl]-2-methylhex-2-enimidic acid
(2e,4e,6s,8r,9r)-n-[(2e,4e,6s,7s,8s)-8-[(2s,3s,4r,5r,6s)-6-[(2e,4e,8e)-2,9-dimethyl-10,12-dimethylidenetetradeca-2,4,8,13-tetraen-1-yl]-3,4,5-trihydroxyoxan-2-yl]-6,7,8-trihydroxy-5-methylocta-2,4-dien-1-yl]-6,8,9-trihydroxy-10-[(2s,2'r,3r,4s,4's,5s,5's,6r,6'r)-3,4,4',5,5'-pentahydroxy-6'-(hydroxymethyl)-6'-methyl-[2,2'-bioxan]-6-yl]deca-2,4-dienimidic acid
(2e,4e,6s,8r,9r)-n-[(2e,4e,6s,7s,8s)-8-[(2s,3s,4r,5r,6s)-6-[(2e,4e,8e)-2,9-dimethyl-10,12-dimethylidenetetradeca-2,4,8,13-tetraen-1-yl]-3,4,5-trihydroxyoxan-2-yl]-6,7,8-trihydroxy-5-methylocta-2,4-dien-1-yl]-6,8,9-trihydroxy-10-[(2s,2'r,3r,4s,4's,5s,5's,6r,6'r)-3,4,4',5,5'-pentahydroxy-6'-(hydroxymethyl)-6'-methyl-[2,2'-bioxan]-6-yl]deca-2,4-dienimidic acid
